Proline rich 13

PRR13
Identifiers
Aliases	PRR13, TXR1, proline rich 13
External IDs	OMIM: 610459; GeneCards: PRR13
RNA expression pattern
	Top expressed in
	duodenum; ; kidney; ; blood; ; rectum; ; bone marrow cell; ; body of stomach; ; monocyte; ; gallbladder; ; appendix; ; spleen;
	n/a
	More reference expression data
	n/a
Gene ontology
Molecular function	protein binding;
Cellular component	nucleus; nucleoplasm; cytosol;
Biological process	regulation of transcription, DNA-templated; transcription, DNA-templated;
	Sources:Amigo / QuickGO
Orthologs
Databases	NCBI: entry
	54458
	n/a
	n/a
	n/a
	Q9NZ81
	n/a
	NM_018457; NM_001005354; NM_001005355
	n/a
	NP_001005354; NP_060927
	n/a
	Wikidata
View/Edit Human

Proline rich 13 is a protein that in humans is encoded by the PRR13 gene.^[2]

References

↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
↑ "Entrez Gene: Proline rich 13". Retrieved 2018-07-11.

Papadaki C, Mavroudis D, Trypaki M, Koutsopoulos A, Stathopoulos E, Hatzidaki D, Tsakalaki E, Georgoulias V, Souglakos J (June 2009). "Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen". Clin. Cancer Res. 15 (11): 3827–33. doi:10.1158/1078-0432.CCR-08-3027. PMID 19435835.
Papadaki C, Tsaroucha E, Kaklamanis L, Lagoudaki E, Trypaki M, Tryfonidis K, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J (January 2011). "Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer". Br. J. Cancer. 104 (2): 316–23. doi:10.1038/sj.bjc.6606027. PMC 3031890. PMID 21157449.
Bi J, Bai Z, Ma X, Song J, Guo Y, Zhao J, Yi X, Han S, Zhang Z (February 2014). "Txr1: an important factor in oxaliplatin resistance in gastric cancer". Med. Oncol. 31 (2): 807. doi:10.1007/s12032-013-0807-1. PMID 24362794. S2CID 207373960.